Aquestive Therapeutics In...

NASDAQ: AQST · Real-Time Price · USD
4.12
0.11 (2.74%)
At close: Aug 14, 2025, 3:59 PM
4.08
-0.84%
After-hours: Aug 14, 2025, 07:56 PM EDT

Aquestive Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
57.56M 50.58M 47.68M 50.83M
Cost of Revenue
17.87M 20.83M 19.39M 14.99M
Gross Profit
39.69M 29.75M 28.29M 35.84M
Operating Income
-30.77M -15.1M -42.07M -34.68M
Interest Income
3.44M 16.32M 99K 423K
Pretax Income
-44.15M -7.63M -54.41M -70.54M
Net Income
-44.14M -7.87M -54.41M -70.54M
Selling & General & Admin
50.18M 31.75M 52.88M 53.48M
Research & Development
20.28M 13.1M 17.48M 17.05M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
70.46M 44.85M 70.36M 70.52M
Interest Expense
16.82M 7.46M 12.44M 22.46M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
88.33M 65.69M 89.75M 85.51M
Income Tax Expense
-14K 245K 5.79M 19.5M
Shares Outstanding (Basic)
86.73M 61.26M 48.73M 38.08M
Shares Outstanding (Diluted)
86.73M 61.26M 48.73M 38.08M
EPS (Basic)
-0.51 -0.13 -1.12 -1.85
EPS (Diluted)
-0.51 -0.13 -1.12 -1.85
EBITDA
-26.62M 1.18M -39.58M -45.11M
EBIT
-27.33M -163K -41.97M -48.08M
Depreciation & Amortization
718K 1.34M 2.39M 2.96M